In conclusion, our study suggests that DHA inhibits the mTOR pathway partially by targeting AKT1 and p70S6K, which attenuates the proliferation of ESCC in vitro and in vivo. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.